EPIQ SCRIPTS Trademark

Trademark Overview


On Tuesday, September 24, 2024, a trademark application was filed for EPIQ SCRIPTS with the United States Patent and Trademark Office. The USPTO has given the EPIQ SCRIPTS trademark a serial number of 98767254. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, September 24, 2024. This trademark is owned by Epiq Scripts IP, LLC. The EPIQ SCRIPTS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Prescription medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Non-prescription medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Compounded medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Dietary and nutritional supplements, namely, hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight loss and weight management supplements
epiq scripts

General Information


Serial Number98767254
Word MarkEPIQ SCRIPTS
Filing DateTuesday, September 24, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, September 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of The mark consists of the words EPIQ and SCRIPTS along with a logo of an E embedded within a stylized S.
Goods and ServicesPharmaceutical preparations for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Prescription medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Non-prescription medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Compounded medications for hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight management, weight loss and the maintenance of weight loss; Dietary and nutritional supplements, namely, hormone replacement therapy, sexual dysfunction, men's health, women's health, skin care, hair loss, weight loss and weight management supplements
Indication of Colors claimedThe color(s) Two tone green colors used, including light green for EPIQ and the stylized E within the logo and dark green for SCRIPTS and the stylized S within the logo is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEpiq Scripts IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRichardson, TX 75080

Trademark Events


Event DateEvent Description
Tuesday, September 24, 2024NEW APPLICATION ENTERED